We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
-19.15%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$13B
AUM Growth
-$3.89B
Cap. Flow
-$375M
Cap. Flow %
-2.88%
Top 10 Hldgs %
25.72%
Holding
872
New
59
Increased
450
Reduced
283
Closed
75

Top Buys

Rank Stock Value
1
AEM icon
Agnico Eagle Mines
AEM
+$114M
2
AGI icon
Alamos Gold
AGI
+$98.3M
3
GG
Goldcorp Inc
GG
+$69.2M
4
NFX
Newfield Exploration
NFX
+$65.7M
5
QCOM icon
Qualcomm
QCOM
+$63.2M

Sector Composition

Rank Sector Weight
1 Materials 39.54%
2 Energy 24.8%
3 Healthcare 8.25%
4 Industrials 5.18%
5 Technology 2.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NLY icon
151
Annaly Capital Management
NLY
$17.3B
$15M 0.11%
378,922
-20,571
-5% -$822K
RUN icon
152
Sunrun
RUN
$2.26B
$14.9M 0.11%
+1,437,900
New +$15.5M
BAP icon
153
Credicorp
BAP
$30.5B
$14.9M 0.11%
140,188
+42,883
+44% +$5.18M
AZN icon
154
AstraZeneca
AZN
$269B
$14.7M 0.11%
231,340
-31,308
-12% -$2.06M
IDXX icon
155
Idexx Laboratories
IDXX
$44.9B
$14.7M 0.11%
197,457
-47,622
-19% -$3.41M
DO
156
DELISTED
Diamond Offshore Drilling
DO
$14.5M 0.11%
836,096
+228,191
+38% +$5.09M
VEON icon
157
VEON
VEON
$3.5B
$14.1M 0.11%
137,231
+23,816
+21% +$2.97M
ABT icon
158
Abbott
ABT
$188B
$13.9M 0.11%
346,769
-12,863
-4% -$606K
UTHR icon
159
United Therapeutics
UTHR
$26.1B
$13.7M 0.11%
104,132
-20,696
-17% -$3.32M
SHPG
160
DELISTED
Shire pic
SHPG
$13.6M 0.1%
66,309
-4,316
-6% -$1.03M
TEVA icon
161
Teva Pharmaceuticals
TEVA
$40.4B
$13.6M 0.1%
240,199
-47,378
-16% -$3.07M
CVS icon
162
CVS Health
CVS
$135B
$13.2M 0.1%
136,455
-10,371
-7% -$1.09M
MHG
163
DELISTED
Marine Harvest ASA
MHG
$13.1M 0.1%
1,035,015
-252,706
-20% -$3.04M
COR icon
164
Cencora
COR
$62B
$12.8M 0.1%
134,736
-3,231
-2% -$339K
ALKS icon
165
Alkermes
ALKS
$8.11B
$12.2M 0.09%
207,748
-42,765
-17% -$2.82M
ALNY icon
166
Alnylam Pharmaceuticals
ALNY
$38.3B
$12.1M 0.09%
150,849
-55,133
-27% -$6.13M
MUX icon
167
McEwen Inc
MUX
$1B
$12.1M 0.09%
1,381,941
-4,567
-0.3% -$37.8K
BHC icon
168
Bausch Health
BHC
$1.75B
$11.7M 0.09%
65,795
-10,424
-14% -$2.43M
GRFS
169
Grifois
GRFS
$5.55B
$11.6M 0.09%
764,340
-138,942
-15% -$2.21M
FMC icon
170
FMC
FMC
$1.25B
$11.5M 0.09%
390,337
-95,520
-20% -$3.7M
ARCC icon
171
Ares Capital
ARCC
$13.4B
$11.4M 0.09%
787,139
+34,164
+5% +$536K
COST icon
172
Costco
COST
$432B
$11M 0.08%
75,863
-2,108
-3% -$301K
EXK
173
Endeavour Silver
EXK
$2.24B
$10.8M 0.08%
6,985,837
-88,450
-1% -$141K
TTC icon
174
Toro Company
TTC
$8.79B
$10.8M 0.08%
306,676
-88,326
-22% -$3.06M
IONS icon
175
Ionis Pharmaceuticals
IONS
$8.93B
$10.7M 0.08%
265,194
-32,421
-11% -$1.68M

Similar funds

VanEck Associates's Q3 2015 Portfolio in Review

As of Q3 2015, VanEck Associates held 872 positions worth $13B, down 23% from $16.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

VanEck Associates's Q3 2015 filing shows 59 new, 450 increased, 283 reduced and 75 closed positions. Its largest new stake was Time Warner Inc: 539,105 shares worth $37.1M. The largest sale was AURICO GOLD INC COM, an estimated $113M.

By sector, the portfolio is most concentrated in Materials at 40% of assets, down from 41% a quarter earlier, followed by Energy and Healthcare.

  • VanEck Associates's largest Q3 2015 buy was Time Warner Inc: 539,105 shares worth $37.1M.
  • VanEck Associates added most to Agnico Eagle Mines in Q3 2015, an estimated $114M increase.
  • VanEck Associates's biggest Q3 2015 reduction was Royal Gold, cutting an estimated $67.6M.
  • VanEck Associates fully exited AURICO GOLD INC COM in Q3 2015, selling an estimated $113M.
  • VanEck Associates's ten largest holdings make up 26% of its $13B portfolio in Q3 2015.
  • VanEck Associates opened 59 new positions and closed 75 in Q3 2015.
  • VanEck Associates's portfolio value fell 23% quarter-over-quarter to $13B.

Based on VanEck Associates's 13F filing for Q3 2015, filed 12 Nov 2015.